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Purpose: We investigated the influence of overweight on 24-hour urine chemistry stud-
ies and recurrent urolithiasis (UL) in children.
Materials and Methods: A retrospective cohort study was designed to assess children 
who presented with UL at a pediatric institution between 1985 and 2010. We calculated 
body mass index percentile (BMIp) adjusted for gender and age according to the 2007 
Korean Children and Adolescents Growth Chart and stratified the children into 3 BMI 
categories: lower body weight (LBW, BMIp≤10), normal BW (NBW, 10＜BMIp＜85), 
and upper BW (UBW, BMIp≥85). Twenty-four hour urine chemistry studies (urine vol-
ume, creatinine, calcium, oxalate, citrate, and pH) were compared between the 3 BMIp 
groups. Univariate and multivariate analyses were performed to assess independent 
risk factors for stone recurrence.
Results: A total of 125 patients were included. The age of the patients in the NBW group 
was older than that of patients in the LBW group, but 24-hour urine chemistry studies 
did not differ significantly between the three groups. Mean urine citrate levels were 
lower (0.273±0.218 mg/mg/d vs. 0.429±0.299 mg/mg/d, p＜0.05) and the incidence of 
hypocitraturia was higher (81.5% vs. 45.7%, p＜0.05)) in the recurrent stone former 
group. In the univariate analysis, hypocitraturia and acidic urinary pH were risk fac-
tors, but in the multivariate analysis, only hypocitraturia was a risk factor for stone 
recurrence (hazard ratio, 3.647; 95% confidence interval, 1.047 to 12.703). In the 
Kaplan-Meier curve, the hypocitraturia group showed higher recurrence than did the 
normocitraturia group (p＜0.05).
Conclusions: Unlike in adults, in children, overweight adjusted for gender and age was 
not associated with 24-hour urine chemistry studies and was not a risk factor for re-
current UL. Hypocitraturia was the only risk factor for UL in children.
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INTRODUCTION
Urolithiasis (UL) in pediatric patients is relatively rare, 
and the prevalence in children varies from 2 to 2.7% [1]. 
Recent studies have shown that the annual incidence is in-
creasing in different populations [2]. Several factors pre-
dispose children to developing UL, and metabolic and geni-
tourinary abnormalities are particularly important; these 
are often associated with diet, environmental factors, and 
infectious causes. UL is associated with considerable mor-
bidity and high recurrence rates. 
　Data about UL in children have increased in recent 
years. Most children with urinary UL have underlying 
metabolic abnormalities, and hypercalciuria is the most 
prevalent [3]. Other metabolic risk factors vary in fre-
quency according to different series [4]. Some metabolic al-
terations that have been described include hypocitraturia, 
hyperuricosuria, hyperoxaluria, renal tubular acidosis, 
and cystinuria [5]. 
　The relationship between body size and risk of UL in Korean J Urol 2012;53:268-274
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adults has been studied extensively [6]. Abnormal urinary 
excretion of calcium, oxalate, and uric acids and abnor-
mally low urinary pH have been linked to increasing body 
weight and body mass index (BMI) [7]. Increasing BMI is 
a risk factor for abnormal 24-hour urine chemistry studies 
in adult stone formers and healthy controls without a his-
tory of UL [8]. Despite these data in adults, however, little 
is known about the relationship between BMI and risk fac-
tors for UL in children. Moreover, little is known about the 
relationship between BMI and the recurrence of UL in 
children. It can be difficult for clinicians to predict which 
children are at risk for stone recurrence after the first stone 
episode. We evaluated 24-hour urine chemistry results in 
children with a history of UL and examined possible corre-
lations between BMI and risk factors for UL. We analyzed 
BMI and 24-hour urine chemistry results in the recurrence 
group and compared the results with those in a cohort with-
out recurrence to determine which patients may need more 
aggressive dietary and pharmacological therapy after the 
first stone episode.
MATERIALS AND METHODS
1. Study design
A retrospective cohort study was designed to assess all chil-
dren less than 18 years of age who presented with UL at 
a single pediatric institution between 1985 and 2010. 
Inclusion criteria were presumed calcium-based renal or 
ureteral stones on the basis of a stone analysis or radio-
graphic imaging, with at least one 24-hour urine chemistry 
study conducted after the initial diagnosis. Exclusion cri-
teria were bladder stones, radiolucent stones (i.e., pre-
sumed uric acid), obstructive uropathy, chronic renal in-
sufficiency, reconstructed lower urinary tract requiring 
clean intermittent catheterization, or patients who were 
taking thiazide diuretics. 
　The diagnosis of UL was made clinically and was con-
firmed in all cases by radiographic imaging, such as ultra-
sonography, excretory urography, or noncontrast compu-
terized axial tomography. Treatment was individualized 
and included watchful waiting for spontaneous passage, if 
suitable, or surgical intervention if obstruction or sepsis 
was present or if a trial of passage had failed. Follow-up 
imaging after passage or surgical treatment included plain 
abdominal radiography and renal ultrasound. 
　Pre-evaluation medical treatment was not controlled, 
but patients generally were advised to begin nonspecific 
therapy. This therapy included recommendations to in-
crease fluid intake to achieve a urine output of at least 1 
to 2 ml/kg per hour. No restriction was made regarding the 
intake of calcium-containing foods (e.g., milk, cheese). BMI 
was calculated as weight in kilograms divided by the 
square of height in meters (kg/m
2) from self-reported pa-
tient height and weight values. 
2. Urine collection
Subjects were given a prescription for a urinary metabolic 
evaluation to be performed at home or at the hospital. One 
or two 24-hour urine collections were performed via spon-
taneous voiding. Internal quality assurance controls were 
adhered to in the laboratory per standard protocols to as-
sess for undercollection and to validate the volume 
measurement. The metabolic evaluation included stand-
ard urinary indexes such as volume, creatinine, calcium, 
oxalate, citrate, and pH. The laboratory methods used to 
evaluate the 24-hour urine samples were calcium-atomic 
absorption spectrophotometry, a citrate-citrate lyase en-
zymatic method, the oxalate-enzymatic method, the crea-
tinine-alkaline picrate method, urinary Becker vol-
ume-volumetric measurement by visual analysis, and uri-
nary pH-reagent test strips with a methyl red and bromo-
thymol blue indicator system. 
3. Statistical analysis
Urine chemistry results were adjusted for 24-hour urinary 
creatinine excretion to account for variations in patient 
size, and urine volume was adjusted for age. Although 
there is no universally accepted cutoff for normal daily uri-
nary citrate excretion in children, a value ＜400 mg/g crea-
tinine was used to define hypocitraturia. Hypercalciuria 
was defined as urinary calcium excretion ＞4 mg/kg and hy-
peroxaluria as oxalate excretion ＞0.57 mg/kg. A low uri-
nary volume was considered when at least one of the sam-
ples had a 24-hour urinary volume ＜15 ml/kg, and acidic 
urine was defined as a pH ＜6.0 [9]. 
　We measured the BMI for each patient at the time of diag-
nosis of UL and then calculated BMI percentile (BMIp), 
which adjusts for gender and age according to the 2007 
Korean Children and Adolescents Growth Chart [10]. 
Patients were stratified into three BMI categories as fol-
lows: lower body weight (LBW, BMIp≤10), normal BW 
(NBW, 10＜BMIp＜85), and upper BW (UBW, BMIp≥85). 
The 24-hour urine chemistry study results were adjusted 
for urinary creatinine and were evaluated among the three 
BMIp categories by analysis of variance, and the incidences 
of hypercalciuria, hypocitraturia, hyperoxaluria, low uri-
nary volume, and acidic urinary pH were compared among 
the three BMIp groups by use of the chi-square test.
Patients who were observed for at least 1 year were 
stratified into two groups of either no recurrence or re-
currence according to the recurrence of UL during the fol-
low-up period. The 24-hour urine chemistry study results 
adjusted for urine creatinine were evaluated between the 
no recurrence and recurrence groups by using the 
Student’s t-test, and the incidences of hypercalciuria, hy-
pocitraturia, hyperoxaluria, low urinary volume, and acid-
ic urinary pH were compared between groups by using the 
chi-square test. Univariate and multivariate analyses 
with the Cox proportional hazard model were performed 
to assess independent risk factors for stone recurrence. 
Each of the categorical independent variables was in-
cluded in the model. This analysis generated an adjusted 
hazard ratio (HR) and 95% confidence interval (CI) for each 
independent variable while controlling for all variables Korean J Urol 2012;53:268-274
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TABLE 1. Patient characteristics
Characteristic Value
Age (yr)    10 (1-18)
Boy 79 (63)
BMI percentile (%)    50 (2-98)
Stone site
    Kidney    41 (32.8)
    Ureteropelvic junction    18 (14.4)
    Upper ureter    39 (31.2)
    Midureter    3 (2.4)
    Lower ureter    32 (25.6)
24-Hr urine chemistry
    Sodium (mmol/mg/d)           0.2 (0.02-1.32)
    Calcium (mg/mg/d)         0.18 (0.01-2.80)
    Citrate (mg/mg/d)           0.31 (0.03-18.28)
    Oxalate (mg/mg/d)         0.03 (0.01-0.36)
    Urine volume (mg)              1,300 (200.0-3,900.0)
    Urine pH       6.5 (5.0-9.0)
Follow-up period (yr) 4.95 (1-20)
No. of recurrences
    0    46 (36.8)
    1    17 (13.6)
    2 or more   10 (8)
    Unknown    52 (41.6)
Values are presented as median (range) or number (%). 
BMI, body mass index.
TABLE 2. Result of 24-Hour urine chemistry accodring to patient body mass index
Variable LBW (n=28) NBW (n=71) UBW (n=26) p-value
Age (yr) 8.21±6.36 11.62±5.75 9.81±5.72 0.031
24-Hr urine chemistry
    Sodium (mmol/mg/d) 0.19±0.09   0.24±0.24 0.26±0.23 0.628
    Calcium (mg/mg/d) 0.37±0.53   0.21±0.21 0.20±0.12 0.065
    Citrate (mg/mg/d)   0.4±0.23   0.39±0.31 0.37±0.27 0.911
    Oxalate (mg/mg/d) 0.06±0.07   0.04±0.04 0.05±0.04 0.71
    Urine volume (mg)  1,466.43±884.14  1,487.89±802.98  1,576.92±891.99 0.871
    Urine pH 6.78±0.70   6.53±0.88      7±0.99 0.345
Hypercalciuria  11 (39.29) 15 (21.13)    6 (23.08) 0.166
Hypocitraturia  13 (46.43) 38 (53.52) 16 (61.54) 0.738
Hyperoxaluria   17 (60.71) 27 (38.03) 12 (46.15) 0.122
Low urine volume  1 (3.57) 12 (16.90)   6 (23.08) 0.114
Acidic urinary pH    9 (32.14) 28 (39.44)   7 (26.92) 0.483
Values are presented as mean±SD or number (%).
LBW, lower body weight; NBW, normal body weight; UBW, upper body weight.
simultaneously. Variables with a 95% CI that did not in-
clude 1.0 were believed to exclude the null hypothesis and 
were considered significant risk factors for developing re-
current stones. We used the Kaplan-Meier curve to de-
termine associations among BMIp, 24-hour urine chem-
istry, and stone recurrence, and any differences in the sur-
vival curves were compared by the log-rank test. SPSS ver. 
14.0 (SPSS Inc., Chicago, IL, USA) was used for the stat-
istical analysis, and p-values less than 0.05 were consid-
ered statistically significant.
RESULTS
We indentified 189 pediatric patients with stones at our in-
stitution, and 125 patients were included in this study. 
Table 1 shows the baseline patient characteristics. The me-
dian age of the patients was 10 years (range, 1 to 18 years), 
79 patients (63%) were boys, and the common sites for 
stones were the kidneys, upper ureter, and lower ureter 
(32.8%, 31.2%, and 25.6%, respectively). Seventy-four pa-
tients (58.4%) were observed for more than 1 year, and the 
median follow-up period was 4.95 years (range, 1 to 20 
years). During the follow-up, 27 (36.5%) of 73 patients expe-
rienced a recurrence, and 10 patients experienced more 
than one recurrence. 
　When we stratified the patients into the LBW, NBW, and 
UBW groups, the number of patients in the groups was 28, 
71, and 26, respectively. The patients in the NBW group 
were older than the patients in the LBW group, but the 
24-hour urine chemistry study results adjusted for urine 
creatinine did not differ significantly among the three 
groups. Moreover, the incidences of hypercalciuria, hypoci-
traturia, hyperoxaluria, low urinary volume, and acidic 
urinary pH were not significantly different (Table 2).
　When we stratified the 73 patients who were observed 
for at least 1 year into two groups of either no recurrence 
or recurrence, there were 46 and 27 patients in the groups, 
respectively. The mean follow-up periods in the no re-
currence and recurrence groups were 4.09±3.48 and 
6.41±4.96 years, respectively, which was not statistically 
different. The incidences of stone recurrence in the LBW, 
NBW, and UBW groups were 36.8% (7 of 19), 48.6% (18 of 
37), and 11.8% (2 patients of 17 patients), respectively, and 
the incidences of stone recurrence in the LBW and NBW 
groups were higher than in the UBW group. The incidence 
of UBW was lower in the recurrence group than in the no Korean J Urol 2012;53:268-274
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TABLE 3. Demographic data and 24-hour urine chemistry results in the no recurrence and recurrence groups
No recurrence group (n=46) Recurrence group (n=27) p-value
Boy 28 (61) 21 (78)  0.138
BMI percentile
    LBW 12 (26)   7 (26) 0.033
    NBW 19 (41) 18 (67)
    UBW 15 (33) 2 (7)
Age (yr) 10.93±5.6 12.81±5.2 0.166
24-Hr urine chemistry 
    Sodium (mmol/mg/d)     0.230±0.214     0.197±0.232 0.588 
    Calcium (mg/mg/d)     0.293±0.414     0.184±0.097 0.201 
    Citrate (mg/mg/d)     0.429±0.299       0.27±0.218 0.026 
    Oxalate (mg/mg/d)     0.056±0.057     0.039±0.005 0.202 
    Urine volume (mg)  1,426.087±871.891  1,712.222±923.444 0.190 
    Urine pH     6.640±0.764     6.473±0.679 0.408 
Hypercalciuria (≥4 mg/kg/d)      12 (26.08)        9 (33.33) 0.509 
Hypocitraturia (≤400 mg/g Cr/d)      21 (45.65)      22 (81.48) 0.001 
Hyperoxaluria (≥0.57 mg/kg/d)      20 (43.47)      12 (44.44) 0.936 
Low urine volume (≤20 ml/kg/d)        7 (15.21)        4 (14.81) 0.963 
Acidic urinary pH (≤6.0)      14 (30.43)      11 (40.74) 0.370 
Follow-up period (yr)     4.09±3.48     6.41±4.96
Values are presented as mean±SD or number (%).
BMI, body mass index; LBW, lower body weight; NBW, normal body weight; UBW, upper body weight.
TABLE 4. Cox proportional analysis for predictive factors for stone recurrence 
Univariate analysis Multivariate analysis
RR CI p-value RR CI p-value
BMI percentile
    LBW 0.908 (0.366-2.255) 0.835 1.06 (0.389-2.889) 0.909
    NBW - - - - - -
    UBW 0.352 (0.080-1.550) 0.352 0.286   (0.06-1.374) 0.118
Hypercalciuria 　 0.897 (0.386-2.086) 0.801 1.311  (0.505-3.4) 0.578
  (≥4 mg/kg/d)
Hypocitraturia 　 3.907   (1.168-13.071) 0.027 3.647   (1.047-12.703) 0.042
  (≤400 mg/g Cr/d)
Hyperoxaluria 1.191 (0.549-2.585) 0.658 1.586 (0.598-4.205) 0.354
  (≥0.57 mg/kg/d)
Low urine volume  1.766 (0.591-5.276) 0.308 2.033 (0.551-7.495) 0.286
  (≤20 ml/kg/d)
Acidic urinary pH  2.399 (1.060-5.427) 0.036 2.056 (0.856-4.936) 0.107
  (≤6.0)
RR, relative risk; CI, confidence interval; BMI, body mass index; LBW, lower body weight; NBW, normal body weight; UBW, upper 
body weight.
recurrence group (33% vs. 7%, p＜0.05), and mean urinary 
citrate levels were lower (0.273±0.218 mg/mg/d vs. 0.429± 
0.299 mg/mg/d, p＜0.05) and the incidence of hypoci-
traturia was higher (81.5% vs. 45.7%, p＜0.05) in the re-
currence group than in the no recurrence group, although 
other lithogenic factors did not differ significantly among 
the groups (Table 3). 
　Univariate and multivariate analyses with the Cox pro-
portional hazard model were performed to assess the in-
dependent risk factors for stone recurrence. In the uni-
variate analysis, hypocitraturia and acidic urinary pH 
were risk factors for stone recurrence, but only hypoci-
traturia was an independent risk factor for stone re-
currence in the multivariate analysis (HR. 3.647; 95% CI, 
1.047-12.703) (Table 4). 
　The Kaplan-Meier survival analysis revealed that the 
group with hypocitraturia (n=43) had a higher and faster 
recurrence rate than did the group with normocitraturia 
(n=30), (p＜0.05), although other 24-hour urine chemistry 
values and BMIp were not significantly different (Fig. 1).Korean J Urol 2012;53:268-274
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FIG. 1. Kaplan-Meier curve estimating the probability of stone recurrence according to patient age and body mass index percentile. 
LBW, lower body weight; NBW, normal body weight; UBW, upper body weight.
DISCUSSION
Mounting evidence in the adult literature points to a causal 
relationship between obesity and urinary stone development. 
Taylor et al. [11] reported a significantly increased risk be-
tween increasing body mass and subsequent kidney stones 
in three large prospective cohorts. A more recent study of 
a large commercial administrative claims database sup-
ported this finding, showing a significant increased risk of 
UL in adults with a BMI＞30 kg/m
2 [12]. Siener et al. [13] 
demonstrated a strong association between obesity and an 
increased risk for stone formation owing to increased uri-
nary excretion of stone-forming risk factors.
　An association between increasing BMI and increasing 
urinary excretion of sodium, calcium, uric acid, and citrate 
has been reported [14]. Adult studies have shown that in-
creased BMI values are a risk factor for increased urinary 
calcium and sodium and decreased urine pH and volume. 
The role of body mass on metabolic parameters has been 
explored to explain the biological mechanisms promoting 
stone formation in overweight and obese individuals. 
Siener et al. [13] noted that increased BMI affects urinary 
homeostasis by increasing factors that promote stone for-
mation, such as decreased urinary pH, increased urinary 
calcium, and increased urinary uric acid excretion. In 
Korea, Jung et al. [15] demonstrated that each metabolic 
syndrome (MS) trait including BMI was a significant litho-
genic factor compared with other lithogenic factors in 
40,687 Koreans at a health promotion center. Moreover, 
Chang et al. [16] reported that MS at baseline and MS over 
time were associated with a significantly increased risk of 
nephrolithiasis and were significantly associated with an 
increased risk of developing urine acidification at follow-up 
in 3,872 men who were reexamined by kidney ultra-
sonography annually or biannually for 8 years.
　The influence of obesity on stone recurrence was inves-
tigated in 704 Korean stone formers, and this study re-
ported that stone recurrence rates were more frequent in 
obese stone formers than in nonobese stone formers. 
Moreover, obese stone formers had a decreased time to 
stone recurrence [17].
　These trends have led some to consider whether a similar 
association exists in children. However, we found no sig-
nificant association between BMI and stone disease in the 
pediatric population. Sarica et al. [18] studied 97 children 
and compared quantitative 24-hour urine chemistry study 
results of overweight children (BMI≥25) with those of con-
trols (BMI＜25). They found that overweight patients ex-
creted significantly greater amounts of oxalate and cal-
cium and significantly less citrate than did controls, all of 
which are known risk factors for nephrolithiasis. Obese 
children have increased urinary metabolic risk factors for 
stone disease, such as hyperoxaluria. However, BMI in-
creases with age. For example, a BMI of 16 in a 3-year-old 
boy places him in the 50th percentile, whereas a BMI of 16 
in a 14-year-old boy falls in the 5th percentile. Because that 
study did not adjust for BMIp, however, it is difficult to com-
pare their results with ours. Our analysis was adjusted for 
age, creatinine excretion, and BMIp to evaluate the associ-
ation between BMI and 24-hour urine chemistry study 
results. We measured BMI in each patient and then calcu-
lated BMIp, which was adjusted for gender and age accord-
ing to the 2007 Korean Children and Adolescents Growth 
Chart [10]. We think that it is very important to adjust 
these confounding factors by the Korean national growth 
chart for BMI to identify the effects of overweight and obe-
sity on UL in children. In the largest pediatric case series 
to date on the role of BMI in the formation of pediatric 
stones, Kieran et al. [19] found no data to support a direct 
role for high BMI in the presentation or treatment of kidney 
stones by using 3 BMI categories according to the Centers 
for Disease Control and Prevention age-adjusted BMI per-
centiles for children, including LBW (10th percentile or 
less), NBW (10th to 85th percentile), and UBW (85th per-
centile or greater). Also, Kim et al. [20] reported that high 
body mass was not associated with UL in a matched Korean J Urol 2012;53:268-274
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case-control study. Thus, we assumed that BMI increases 
with age, and that children grow annually unlike adults. 
Moreover, the physical growth of children is different from 
that of adults, indicating that BMI in adults is commonly 
fixed, whereas BMI in children could change over time. 
Therefore, these preliminary findings suggest that the 
pathophysiology of pediatric stone formation may be dis-
tinctly different from that in the adult population, but fur-
ther large-scaled prospective studies are needed to confirm 
these results.
　Metabolic abnormalities are commonly found in the pe-
diatric stone-forming population, and a full metabolic eval-
uation is often performed after the first stone episode [21]. 
Metabolic disorders are present in 12.3 to 96% of children 
with UL. Idiopathic hypercalciuria is the most frequent 
urinary metabolic risk factor found and is detected in 40 
to 69% of cases [22]. Acar et al. [23] reported the incidence 
of idiopathic hypercalciuria as the most common factor in 
40% of cases. Tefekli et al. [24] found that hypocitraturia 
is the most prevalent metabolic risk factor in children, and 
Van Dervoort et al. [2] also observed that hypocitraturia 
is the most commonly identified metabolic abnormality, 
which was present in 52% of the children studied between 
2003 and 2005. Moreover, children with identified meta-
bolic abnormalities had higher recurrence rates than did 
those without abnormalities [25]. In our study, hypoci-
traturia was the only risk factor for pediatric UL and stone 
recurrence. We believe that our data support the recom-
mendation that all children with UL should undergo a met-
abolic evaluation and those with positive findings should 
be followed carefully for evidence of symptomatic or asymp-
tomatic stone recurrence. On the basis of our results, we 
believe that the effect of obesity on UL in children is differ-
ent from that in adults and that metabolic problems are 
more important lithogenic factors than is obesity in 
children. 
　There are several limitations to our study. First, it was 
retrospective in nature and thus is subject to the short-
comings of a nonprospective design and the relatively small 
number of subjects compared with the adult cohort. 
Second, the data were somewhat underpowered to stratify 
the pediatric group by gender or into prepubertal and post-
pubertal age groups. The pediatric cohort did not include 
many infants or young children owing to the difficulty of 
obtaining 24-hour urine collections from non-toilet-trained 
children. Although we did not include genetic and environ-
mental factors, the ratio of a family history component var-
ies from 12 to 50% in different studies [26]. This may sug-
gest a significant contribution of genetic factors to the 
pathogenesis of urinary stones.
CONCLUSIONS
Unlike in adults, overweight, adjusted for gender and age, 
was not associated with 24-hour urine chemistry results 
and was not associated with UL in children. Hypocitraturia 
was a predictive factor for stone recurrence in children. 
Thus, the physiopathology of UL in children may be differ-
ent from that in adults, and more prospective studies are 
needed to better understand the determinants of UL in 
children.
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